Oxford Club's 'America Reloading' — The Five Defense Stocks Behind Mark Skousen's January 2027 Deadline

The Hook

Mark Skousen has a new pitch out for his Oxford Club-backed Skousen Intelligence Alert, and it opens with a countdown clock: January 1, 2027. That’s the date when, under current federal regulations, U.S. defense contractors must stop buying rare earths, magnets, tungsten, molybdenum, and tantalum from China, Russia, Iran, and North Korea.

The promo frames this as the catalyst for “the biggest military buildout in 75 years”, a $1.5 trillion defense budget that includes a 240-fold increase in drone spending, a $305 billion “Golden Fleet” to rebuild the Navy, and a wholesale reshoring of critical mineral supply chains. Skousen has five stock picks he says are positioned to profit from this spending wave.

“Time Is Short!” the order form warns. “Trump’s January 1 Ban Is Set to Hit, and These Stocks Won’t Stay at $10 for Long.” Unlike Alexander Green’s measured Oxford Communiqué pitch, this one is pure urgency.

The Big Claim

Skousen is selling a thematic bet on defense spending under the Trump administration, with a specific catalyst: the January 1, 2027 deadline for removing Chinese-sourced critical minerals from U.S. defense systems. This deadline is real, Reuters reported in late July that the defense industry is now “just over five months away” from compliance.

Each of the five picks targets a different angle: drones (RCAT), precision aerospace parts (SIF), naval shipbuilding (HII), antimony supply (UAMY), and rare earth processing (ALOY). Skousen pitches potential 10-20X returns on the smaller names and steady growth on the larger one.

The subscription is $1,995/year, steep by newsletter standards, and has an unusual refund policy: you can only request your money back if all five picks have a negative average return by January 1, 2027. That’s a bet on the portfolio, not an individual stock guarantee.

The Mechanism

Pick 1: Red Cat (RCAT), Drones

The promo describes Red Cat as America’s drone champion: producing 1,000 drones per month, 128% revenue growth, contracts under the Pentagon’s Drone Dominance program and Army Short Range Reconnaissance. It also credits them with building “unmanned drone aircraft carriers.”

Red Cat is real. They manufacture the Black Widow drone at their Utah facility, and revenue growth has been legitimate, $275 million projected for 2028 against a $1.6 billion market cap. They have a $167 million cash balance. The National Defense Authorization Act includes dramatic increases in drone procurement, and the ban on foreign-made drones for U.S. defense is real policy.

The “aircraft carrier,” however, is an 8-meter unmanned surface vessel called Variant 7, a speedboat that can launch smaller drones, not a naval warship. And the revenue growth comes with a catch: the share count has roughly doubled over the past year as Red Cat uses stock to acquire new drone technologies. That dilutes per-share value even as the top line grows. The stock trades around $10, up 34% from Skousen’s $7.45 tease price, but down from $20 just a few months ago.

Pick 2: Sifco Industries (SIF), Aerospace Parts

Sifco makes precision-engineered components and superalloys for military and commercial aviation. The customer list is genuinely impressive: the Defense Logistics Agency, the Navy, Lockheed Martin, Northrop Grumman, Boeing, Airbus. Three years of revenue growth, recently profitable, PE ratio around 18x.

The catch is size. Sifco’s market cap is roughly $170 million, meaning the “16-fold move to $2 billion” Skousen mentions is coming from a very small base. The stock trades at $21.80, down 18% from the $26.65 tease price. Average daily volume is just 122,000 shares, not a stock you can easily buy or sell in size. There is zero analyst coverage, so you’re doing your own homework entirely.

Pick 3: Huntington Ingalls (HII), Shipbuilding

This is the strongest pick in the group by almost any measure. Huntington Ingalls is the sole builder of U.S. aircraft carriers, a business with a $76.6 billion backlog and a 50-year lifecycle per vessel. They also build destroyers and Columbia-class submarines.

HII just reported Q2 earnings: $3.42 billion in revenue, $5.27 EPS, both above expectations. The stock trades around $331, up 10% from the $299 tease price. At 16x forward earnings with expected 10-15% annual earnings growth, it’s actually reasonably priced. They pay a $1.38 quarterly dividend (~1.7% yield).

The risk is not execution — it’s strategic. Aircraft carriers cost $10-12 billion each, and one of the uncomfortable questions defense planners are asking is whether a few thousand cheap drones could take one down. If the military’s thinking shifts from “more carriers” to “different platforms,” HII’s moat narrows. But for now, the backlog is real and the earnings are solid.

Pick 4: United States Antimony (UAMY), Critical Minerals

UAMY produces antimony, a critical mineral used in flame retardants, batteries, and munitions. They hold a $245 million contract with the Defense Logistics Agency, a headline number that sounds enormous for a company with $40 million in annual sales.

The fine print: that’s a five-year contract, so about $49 million per year. Some of UAMY’s antimony comes from imported ore (Peru, Australia, Bolivia), which means they’re not purely a domestic-play story. The company has mining claims in Alaska and Montana, plus a tungsten deposit, but bringing new domestic production online takes years and capital. This is the same critical minerals space we explored with Dylan Jovine’s Gold War pitch, where the national security case is compelling but the near-term stock performance is volatile.

The stock trades at $6.67, up 28% from the $5.21 tease price but way down from its $19+ highs earlier this year. Q2 revenue jumped 187% year-over-year, and analysts see a path to $300 million in 2028 revenue with 30 cents EPS. If antimony prices stay elevated, China has been restricting exports, the thesis has legs. But this is a penny stock that moves violently on sentiment.

Pick 5: REalloys (ALOY), Rare Earth Processing

The most speculative of the five. REalloys came public via SPAC merger in February 2026 and is building a rare earth processing and magnet manufacturing facility in Ohio. They appointed Joe Kasper, Pete Hegseth’s former Chief of Staff, as Advisory Board Chair, a sign of political connections.

The company is pre-revenue. Their processing facility won’t be operational until 2027-2030 at the earliest. The “99% purity” claim refers to a capability demonstration, not ongoing production. Market cap is roughly $660 million, a lot for a company with no revenue.

The stock is the best performer of the bunch, up 77% from the $7.33 tease price to $12.98. That’s narrative-driven momentum, not earnings-driven. If the rare earth magnet story catches fire with investors, ALOY could keep running. If development hits delays or the January 2027 deadline gets softened, it could give back those gains quickly.

The Real Picks

Does the Math Check Out?

Average return across the five picks since tease: +26.3%, so Skousen’s refund guarantee (negative average return triggers a refund) is already out of the money. If you subscribed today, you’d be buying in after the initial pop.

The 10-20X claims for RCAT, SIF, UAMY, and ALOY are based on the assumption that defense spending flows to these specific small companies in proportion to their current market caps. That’s a big assumption. The Pentagon’s procurement process is slow, political, and favors incumbents. Small companies win contracts, but they don’t always scale smoothly, RCAT’s share dilution and SIF’s liquidity constraints are real-world friction that 10X projections tend to ignore.

The January 1, 2027 deadline for the Chinese rare earth ban is real, Reuters confirmed it. But Reuters also reported that the defense industry is struggling to meet it, and there’s already discussion about whether the deadline will need to be extended or softened. If it is, the urgency mechanism that drives Skousen’s pitch loses its teeth. This is a pattern we’ve seen before in defense-themed promo pitches, real policy catalysts don’t always translate to stock gains on the timeline the promos promise.

HII at 16x forward earnings with a $76B backlog and 10-15% growth? That math works. It’s the only pick in the group that doesn’t require heroic assumptions. The rest are bets on policy timing and investor sentiment as much as on company execution.

What They Got Right

1. The January 2027 deadline is real. This is not a fabricated catalyst, it’s a documented federal regulatory requirement that Reuters, CSIS, and other serious outlets have covered. The defense supply chain genuinely needs to reshore critical minerals, and that creates opportunity.

2. HII is genuinely well-positioned. As the sole aircraft carrier builder with a multi-decade backlog and steady earnings growth, HII is a rational defense investment regardless of whether you buy the urgency narrative.

3. The drone spending increase is documented. The National Defense Authorization Act does include dramatic increases in drone procurement, and the ban on foreign-made drones for U.S. defense is real policy. Red Cat’s U.S.-based manufacturing is a genuine competitive advantage.

4. Antimony prices are rising on Chinese export restrictions. UAMY’s revenue growth tracks a real supply-chain shift. The DLA contract, while smaller annually than the headline number suggests, is real government business.

5. The rare earth magnet supply chain is a legitimate national security concern. China controls roughly 90% of rare earth processing and magnet production. Building domestic capacity is a bipartisan priority, and ALOY is positioned in that space, even if the timeline is long.

What They Got Wrong

1. The “aircraft carrier” claim for RCAT is an exaggeration. Red Cat’s Variant 7 is an 8-meter unmanned surface vessel, a drone boat, not an aircraft carrier. Calling it an “unmanned drone aircraft carrier” is misleading about the scale of the technology.

2. UAMY’s $245 million contract is presented as if it’s annual. The promo says “$245 million contract, six times their current annual sales of $40 million,” implying the contract is per-year. It’s not. The annual run-rate is about $49 million. That’s still significant, but it’s a different order of magnitude than what the framing suggests.

3. ALOY is pre-revenue with a 2027-2030 development timeline. Pitching it alongside operating companies with real revenue (HII, RCAT) obscures how speculative it is. ALOY could be a great company someday, but it’s a development-stage bet, not a “ride the spending wave” trade.

4. RCAT’s dilution story is unmentioned. Revenue growth is impressive, but the share count has roughly doubled over the past year. Per-share value hasn’t grown at the same rate as top-line revenue. That matters for anyone holding the stock, not just the company’s PR department.

5. SIF’s “16-fold to $2 billion” framing stretches credibility. Starting from a $170 million market cap, a 16-fold move gets you to about $2.7 billion, but framing it as “a near 16-fold move to a $2 billion valuation” makes it sound like the destination is modest when the starting point is micro-cap territory. For a company with zero analyst coverage and 122K average daily volume, that’s a paper return that would be nearly impossible to realize at scale.

The Verdict

There is a genuinely interesting thesis here: the confluence of defense spending increases and supply-chain reshoring creates real opportunities in small defense and critical mineral stocks. The January 2027 deadline is a legitimate catalyst.

Of the five picks, HII stands out as a solid, reasonably priced company with real earnings and a durable competitive position. RCAT has genuine growth but comes with dilution risk. UAMY has a real government contract but is a penny stock. SIF is too small and illiquid for most investors. ALOY is a pre-revenue development-stage bet that could pay off, but might take until 2030 to find out.

If you’re interested in the defense spending thesis, the smarter play might be: own HII for the steady exposure, then decide whether you want to speculate on the smaller names with position sizes appropriate for high-risk bets. Don’t let the countdown clock rush you into five stocks at once.

NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research. The Skousen Intelligence Alert promo’s own disclaimer notes that “past performance is no guarantee of future results” and that small-cap and micro-cap stocks carry above-average risk of loss.